Treatment considerations in myasthenia gravis for the pregnant patient
Open Access
- 20 February 2023
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 23 (2) , 169-177
Abstract
Myasthenia gravis (MG) is an autoimmune disease where muscle antibodies form against the acetylcholine receptor (AChR), MuSK, or LRP4 at the neuromuscular junction leading to weakness. Patients wor...Keywords
This publication has 78 references indexed in Scilit:
- Ten-Year Results of Thoracoscopic Unilateral Extended Thymectomy Performed in Nonthymomatous Myasthenia GravisAnnals of Surgery, 2011
- Corticosteroid use during pregnancy and risk of orofacial cleftsCanadian Medical Association Journal, 2011
- Utilizing Twins Concordance Rates to Infer the Predisposition to Myasthenia GravisTwin Research and Human Genetics, 2011
- Myasthenia gravis requiring pyridostigmine treatment in a national population cohortEuropean Journal of Neurology, 2010
- Guidelines for treatment of autoimmune neuromuscular transmission disordersEuropean Journal of Neurology, 2010
- SEROPOSITIVE MYASTHENIA GRAVIS: A NATIONWIDE EPIDEMIOLOGIC STUDYNeurology, 2009
- Can neonatal myasthenia gravis be predicted?Journal of Perinatal Medicine, 2008
- Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising careEuropean Journal of Neurology, 2007
- Genetic Analysis of Autoimmune DiseaseCell, 1996
- GENETIC ASPECTS IN MYASTHENIA GRAVISActa Neurologica Scandinavica, 1977